The Challenges of Reliance on Insulin-Like Growth Factor I in Monitoring Disease Activity in Patients with Acromegaly

Publisher： Karger

E-ISSN： 1663-2826|62|1|83-88

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.62, Iss.1, 2005-03, pp. : 83-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acromegaly and Serum Insulin-Like Growth Factor I

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 1, 2005-03 ,pp. : 34-36

Karger

Access to resources Recommend Favorite

The PPAR-Gamma Activator Rosiglitazone Fails to Lower Plasma Growth Hormone and Insulin-Like Growth Factor-1 Levels in Patients with Acromegaly

By  

Neuroendocrinology, Vol. 86, Iss. 2, 2007-08 ,pp. : 119-123

Karger

Access to resources Recommend Favorite

Defining Insulin-Like Growth Factor-I Deficiency

By  

Hormone Research in Paediatrics, Vol. 65, Iss. 1, 2006-03 ,pp. : 9-14

Karger

Access to resources Recommend Favorite

Exercise and Circulating Insulin-Like Growth Factor I

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 1, 2005-03 ,pp. : 50-58

Karger

Access to resources Recommend Favorite

Pitfalls of Insulin-Like Growth Factor I Assays

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2009-01 ,pp. : 30-33

Karger

Access to resources Recommend Favorite